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Purpose: To investigate the association between the serum high sensitivity C-reactive protein (hs-CRP) levels and variants
in age-related maculopathy susceptibility 2 (ARMS2)/HtrA serine peptidase 1 (HTRA1) genes in normal subjects with no
evidence of age-related macular degeneration (AMD).
Methods: After clinical evaluation, information related to medical and social history was collected from 476 Japanese
individuals (age range 17–89 years) along with blood samples. These subjects were medical checkup participants recruited
at Nagoya University Hospital with no macular disease, as confirmed by fundus photographs. Serum hs-CRP levels were
measured using a highly sensitive latex aggregation immunoassay. The genotypes of three polymorphisms in the ARMS2/
HTRA1 locus, i.e., *372_815del443ins54 (del/ins), rs10490924, and rs11200638 were determined using direct sequencing
and/or PCR-based assays. After the haplotype was constructed and analyzed, the associations between hs-CRP levels and
representative del/ins genotypes were studied with and without adjustment for potential confounding factors.
Results:  All  three  polymorphisms  in  the  ARMS2/HTRA1  region  were  in  almost  complete  linkage  disequilibrium.
Haplotype analyses showed the existence of only two common haplotypes, together comprising 98.9%. Regression
analyses showed that the level of hs-CRP was positively correlated with increasing age. This age-dependent increase of
hs-CRP levels was greatest in those with homozygous del/ins alleles and lowest in those with homozygous wild-type
alleles, which was significant assuming an additive model for gene-dosage association (univariate analyses: p=0.016,
multivariate analyses including smoking status, past medical history, and BMI: p=0.043). Consequently, the level of hs-
CRP was greatest in those with homozygous del/ins alleles and lowest in those with homozygous wild-type alleles when
subjects older than 60 were analyzed. This was significant assuming an additive model for gene-dosage association
(univariate analyses: p=0.032).
Conclusions: An age-dependent elevation of serum hs-CRP levels may be accelerated in normal subjects with one or two
risk alleles in the ARMS2/HTRA1 locus compared to those with homozygous wild-type alleles. The results of the current
study show that the as-yet undetermined function of variants in the ARMS2/HTRA1 locus might be linked to inflammation,
possibly contributing to the development of neovascular AMD.
Advanced age-related macular degeneration (AMD) is a
major  cause  of  legal  blindness  in  elderly  people  in
industrialized countries [1-3]. In Asian populations, including
Japanese people, most vision-threatening cases of AMD are
of the neovascular type, although central geographic atrophy
is  less  frequent  [4,5].  The  cause  of  AMD  is  complicated
because  multiple  genetic  and  environmental  factors  are
involved in its pathogenesis. Epidemiological studies have
indicated that factors such as age, smoking, gender, obesity,
hypertension,  and  genetic  background  are  associated  with
AMD  [4,6].  Recent  progress  in  research  on  AMD  has
provided  increasing  evidence  that  inflammatory  processes
[3,7-10]  and  oxidative  stress  [3,10,11]  contribute  to  the
pathogenesis of AMD. One well documented alteration of
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inflammatory markers in AMD patients is the elevation of the
serum C-reactive protein (CRP) level [4,12-15]. These levels
are also associated with disease progression [16].
Among the several disease-associated genetic variations
reported to date [17], those in the 10q26 area are the major
genetic  risk  factors  for  AMD  in  Asian  people  [18-20].
Meanwhile, a polymorphism in another genetic locus (1q32,
Y402H  variant  in  the  complement  factor  H  [CFH]  gene)
strongly  influences  the  pathology  in  Caucasian  people
[21-23]. Currently, two genes residing in the 10q26 area- age-
related maculopathy susceptibility 2 (ARMS2), also called
LOC387715,  and  HtrA  serine  peptidase  1  (HTRA1)  are
potential  candidates  to  be  classified  as  the  AMD-
susceptibility gene [18,20]. The risk variants in the ARMS2/
HTRA1  genes  include  *372_815del443ins54  (del/ins)
polymorphism [24] and rs10490924 and rs11200638 single
nucleotide  polymorphisms  (SNPs)  [20].  The  del443ins54
polymorphism, residing within the polyadenylate region of
the ARMS2 gene, might reduce ARMS2 protein expression
Molecular Vision 2010; 16:2923-2930 <http://www.molvis.org/molvis/v16/a314>
Received 8 August 2010 | Accepted 25 December 2010 | Published 31 December 2010
© 2010 Molecular Vision
2923[24] and might paradoxically increase the level of HTRA1
gene products through unknown mechanisms [25]. To date,
no  analysis  of  the  biologic  consequence  of  the  SNP
rs10490924 causing a missense alteration (Ala69Ser) in the
ARMS2  gene  has  been  reported.  The  function  of
rs11200638, located in the promoter region of the HTRA1
gene, is controversial; reports have described both increased
and unchanged transcription of the gene as a result of the
variant [25-27]. Moreover, these three variants are mutually
indistinguishable  using  genotype-phenotype  association
analyses  because  they  are  in  almost  complete  linkage
disequilibrium, all residing within approximately 6 kb [24].
Therefore, the mechanisms underlying the contributions of
these variants to the pathogenesis of AMD remain unclear.
This study examined the relationship between ARMS2/
HTRA1 gene variants and serum high sensitivity CRP (hs-
CRP)  levels  in  normal  individuals  to  assess  the  biologic
effects of the risk allele.
METHODS
Study  subjects:  The  research  protocol  was  designed  in
compliance with the Declaration of Helsinki and approved by
the  institutional  review  board  of  the  Nagoya  University
School of Medicine. Written informed consent for providing
medical information and blood samples was obtained from
each participant. All subjects were ethnic Japanese, residents
of the same area of Japan (Chubu, central Japan), and were
enrolled in disease prevention programs at Nagoya University
Hospital. They were all reportedly unrelated. Most subjects
included in this study were described in a previous report [4].
Among the examinees, only subjects with no evidence of
even the early stages of AMD, including drusen formation,
were selected after evaluation of the fundus photographs by
ophthalmologists.  Consequently,  476  subjects  with  no
macular degeneration (291 men, 185 women) were recruited
[4,28].
Health  and  lifestyle  factors:  All  participants  completed  a
health and lifestyle questionnaire, including questions related
to smoking and alcohol consumption. The height and weight
of each patient was recorded and body mass index (BMI) was
calculated as mass (kg) divided by height squared (m2).
CRP Analysis: Serum hs-CRP levels were measured using a
highly  sensitive  latex  aggregation  immunoassay  (Nanopia
CRP; Daiichi Pure Chemicals Co. Ltd., Tokyo, Japan) with
an analyzer (Hitachi 7170; Hitachi High-Technologies Co.,
Ltd. Tokyo, Japan). The lower limit of detection was 0.03 mg/
l. The high reproducibility of this assay has been reported
previously [4].
Genotyping: The genotypes of ARMS2/HTRA1 variants were
determined using direct sequencing and/or PCR-based assays
[4]. In brief, genomic DNAs were extracted from peripheral
blood using a kit (QIAamp DNA Blood Maxi; Qiagen Inc.,
Tokyo, Japan). The DNA fragments, including the variants,
were amplified using PCR. To determine the genotypes of
rs10490924  and  rs11200638  in  the  ARMS2/HTRA1  locus,
sequences were extracted using a BigDye Terminator v3.1
Cycle Sequencing Kit (Applied Biosystems, Tokyo, Japan)
and  a  genetic  analyzer  (ABI  Prism  3100;  Applied
Biosystems).  The  genotypes  of  the  del/ins  variants  in  the
ARMS2/HTRA1 locus were studied based on the size of the
PCR-amplified  DNA  fragments  visualized  in  agarose  gel
electrophoresis  and/or  by  direct  sequencing,  as  described
above.
Statistical analysis: The indexes of linkage disequilibrium
(D’)  among  three  ARMS2/HTRA1  polymorphisms  were
calculated.  The  expectation-maximization  algorithm  was
applied  to  estimate  and  analyze  the  haplotypes  of  these
polymorphisms.  Analyses  to  compare  the  demographic
characteristics among the three different del/ins genotypes,
representing  three  combinations  of  two  different  major
haplotypes, were performed either using the Kruskal–Wallis
test  (age  average),  median  test  (age  median),  exact  test
(gender, medical history, and smoking and drinking habits),
or analysis of variance (ANOVA; BMI). Hardy–Weinberg
expectations  were  tested  using  exact  tests  [29].  Linear
regression analysis was performed to examine the association
between the hs-CRP levels and age. For multiple regression
analyses  applied  to  control  for  the  demographic
characteristics, an additive (but not dominant or recessive)
gene-dosage model was assumed, as suggested previously
[18]. Furthermore, linear regression analysis was performed
to estimate the effect of haplotype on hs-CRP, assuming an
additive,  dominant,  and  recessive  gene-dosage  model.
Differences in hs-CRP levels on a natural logarithmic scale
(showing  a  normal  distribution)  between  genotypes  were
examined using t-tests and ANOVA.
For the calculations, PASW Statistics 18 (SPSS Inc., IBM
Japan,  Ltd.,  Tokyo,  Japan)  and  R  (The  R  Foundation  for
Statistical Computing; genetics and haplo.stats library) [30]
were used; p<0.05 was considered significant.
RESULTS
Distributions  of  ARMS2/HTRA1  genotypes:  The  three
polymorphisms  analyzed  in  the  current  study––del/ins
polymorphism, SNP rs10490924, and SNP rs11200638-were
in  almost  complete  mutual  linkage  disequilibrium
(D’>0.9997),  which  was  further  supported  by  haplotype
analyses  showing  the  existence  of  only  two  common
haplotypes  in  the  relevant  genomic  region,  together
comprising  98.9%  (Table  1).  This  assures  there  is  little
difference in overall interpretation of the present data for all
three polymorphisms. Therefore, we indiscriminately chose
and  analyzed  del/ins  polymorphisms  to  represent  the
genotypes  of  ARMS/HTRA1  loci.  To  avoid  confusion,
homozygotes with two wild-type alleles, heterozygotes with
one del/ins allele, and homozygotes with two del/ins alleles
are designated respectively as wild-types, heterozygotes, and
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2924homozygotes. In this case, the del/ins allele is the AMD risk
allele [24]. The respective frequencies of genotypes for the
wild-types, heterozygotes, and homozygotes were 176 (37%),
236 (50%), and 64 (13%), as shown in Table 2. The result of
a  Hardy-Weinberg  equilibrium  test  showed  no  marked
deviation  from  the  expected  distribution  of  genotypes
(p=0.119).
Demographic  characteristics  of  study  subjects:  The
demographic characteristics of all participants are presented
in  Table  2.  The  medical  and  social  backgrounds  of  the
participants were compared among three different genotypes
in del/ins locus in normal subjects (mean age of 49.7 years;
range  17-89).  No  significant  difference  in  background
characteristics  was  found  between  genotypes,  except  for
drinking habits (Table 2). A small difference in the smoking
history was not significant (p=0.061).
Accelerated increase of hs-CRP levels with aging in subjects
with del/ins variants: The relationship between the measured
hs-CRP levels and age is displayed in scatter plots (Figure 1A)
and in Table 3, which revealed an age-dependent increase in
the levels. The regression coefficients were 0.022 (R=0.238,
p<0.001;  Table  3).  When  the  association  was  analyzed
separately for three different del/ins genotypes (Figure 1B-D),
the hs-CRP levels were correlated significantly with age in
heterozygotes and homozygotes. Correlation was weak and
non-significant among wild-types. The respective regression
coefficients were 0.009 (R=0.105, p=0.06), 0.026 (R=0.280,
p<0.001),  and  0.040  (R=0.351,  p=0.004)  for  wild-types,
heterozygotes,  and  homozygotes.  These  results  showing
higher coefficients in those with AMD risk variants were
significant (p=0.016), indicating that the increase in hs-CRP
levels with aging was accelerated in those with del/ins alleles
TABLE 1. ESTIMATED HAPLOTYPE FREQUENCIES.
Category rs10490924 del-ins rs11200638 haplotype frequency
Haplotype        G (wild-type)                           wild-type           G (wild-type) 61.77%
  T (risk) del-ins A (risk) 37.19%
  G (wild-type) del-ins A (risk) 0.95%
  T (risk) del-ins              G (wild-type) 0.11%
         Haplotype  frequencies  were  estimated  using  expectation-maximization  algorithm,  which  were  presented  in  the  order  of
         frequency (top to bottom).
TABLE 2. DEMOGRAPHIC CHARACTERISTICS BY *372_815DEL443INS54 GENOTYPES.
  *372_815del443ins54 genotype
Category Wild-type Heterozygote Homozygote Total p value
number 176 (37.0%) 236 (49.6%) 64 (13.4%) 476 0.11
age average (SD) 49.9 (12.1) 49.0 (13.3) 51.8 (12.6) 49.7 (12.8) 0.29
age median (range) 49 (26–77) 49 (17–89) 53 (25–81) 49 (17–89) 0.36
female gender 65 (36.9%) 88 (37.3%) 32 (50.0%) 185 (38.9%) 0.14
BMI average (SD) 23.0 (3.1) 22.6 (3.1) 22.4 (2.8) 22.7 (3.1) 0.38
History of
hypertension 17 (15.6%) 32 (13.6%) 10 (9.7%) 59 (12.4%) 0.32
hyperlipidemia 22 (12.5%) 32 (13.6%) 13 (20.3%) 67 (14.1%) 0.29
diabetes 7 (4.0%) 9 (3.8%) 3 (4.7%) 19 (4.0%) 0.89
stroke 6 (3.4%) 5 (2.1%) 4 (6.3%) 15 (3.2%) 0.2
cardiovascular disease 2 (1.1%) 9 (3.8%) 2 (3.1%) 13 (2.7%) 0.23
Smoking habit
present 38 (21.6%) 48 (20.3%) 9 (14.1%) 95 (20.0%)  
former 50 (28.4%) 74 (31.4%) 11 (17.2%) 135 (28.4%) 0.061
never 88 (50.0%) 114 (48.3%) 44 (68.8%) 246 (51.7%)  
Drinking habit
once a week or more 88 (50.0%) 132 (55.9%) 23 (35.9%) 243 (51.1%)  
occasional 9 (5.1%) 10 (4.2%) 2 (3.1%) 21 (4.4%) 0.049
no drinking habit 79 (44.9%) 94 (39.8%) 39 (60.9%) 212 (44.5%)  
         Demographic characteristics were shown according to *372_815del443ins54 genotypes. P values were calculated to statistically
         evaluate the  differences among three groups. Exact test of Hardy–Weinberg equilibrium (number), Kruskal–Wallis test (age
         average), median test (age median), exact test (gender, medical history, and smoking and drinking habit), ANOVA (BMI) were
         applied to calculate P values. Abbreviations: SD, standard deviation; BMI, body mass index
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2925compared to those without. Next, we examined whether the
conclusions  hold  true  after  adjustment  for  demographic
characteristics.  Analyses  of  the  effects  of  demographic
characteristics  (age,  gender,  smoking  habits,  alcohol
consumption,  BMI,  and  past  medical  history)  and  del/ins
genotypes on serum hs-CRP levels revealed interaction of age
and del/ins genotypes (two-factor interaction; p=0.043) as an
independent influential factor. Additionally, BMI (p<0.001)
and a history of stroke (p=0.012) were shown to affect the hs-
CRP levels. The overall explanatory power of the multivariate
analyses was 0.183 (meaning that 18.3% of variation in the
hs-CRP levels could be explained by all factors, including
genotypes,  ages,  and  other  demographic  characteristics,
analyzed in the multivariate analyses).
We further assessed the association of age and hs-CRP
between  haplotypes  and  assessed  the  difference  in  the
regression coefficients using two-tailed analyses (Table 3).
Analyses  of  haplotypes  required  an  assumption  about  the
mode of influence (dominant, recessive, or additive model).
Therefore,  analyses  identical  to  those  for  genotypes  were
impossible.  Results  showed  that  the  risk  haplotype  had  a
significantly  larger  regression  coefficient  assuming  an
Figure 1. Scatter plots of ages and serum hs-CRP levels (mg/l). Panel A was derived from all subjects comprising three genotypes. Panels
B-D, respectively show data from wild-types, heterozygotes, and homozygotes. The linear regression equations are shown as solid, straight
lines. Abbreviations: CRP represents C-reactive protein.
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2926additive model (p=0.027), but not a dominant (p=0.054) or a
recessive model (p=0.15).
Elevated Serum hs-CRP levels in subjects with del/ins variant:
Among all subjects, geometric means of the serum hs-CRP
levels were, respectively, 0.37, 0.35, and 0.41 mg/l for wild-
types, heterozygotes, and homozygotes. These differences in
hs-CRP  levels  were  not  significant  (p=0.82;  Table  4).
However, when subjects old enough to develop AMD were
selected (more than 60 years old) and examined, means of the
serum  hs-CRP  levels  were,  respectively,  0.35,  0.60,  and
0.71 mg/l for wild-types, heterozygotes, and homozygotes.
These differences in hs-CRP levels were significant (p=0.032;
Table 4). Meanwhile, when the means of hs-CRP levels were
compared between younger and older groups within the same
genotype, levels were significantly lower in younger subjects
than in those over 60 years old in the heterozygotes group
(p<0.001, 0.30 versus 0.60 mg/l), but not in the homozygotes
group (p=0.15, 0.34 versus 0.71 mg/l) or the wild-types group
(p=0.69, 0.38 versus 0.35 mg/l).
TABLE 3. REGRESSION ANALYSES OF HS-CRP LEVELS.
Genotype    
372_815del443ins54 genotype p value † p value ‡
Wild-type logarithm of serum
CRP=
0.0097x [Age]-3.7 0.063  
Heterozygote 0.025x [Age]-4.6 2.4×10−7 0.016
Homozygote 0.039 x [Age]-5.2 0.0041  
Total 0.022x [Age]-4.4 2.9×10−7  
Effect of risk haplotype
gene-dosage model estimated regression coefficients (age) p value
Dominant wild-type 0.0098 0.054
  heterozygote + homozygote 0.027  
Recessive wild-type + heterozygote 0.02 0.15
  homozygote 0.04  
Additive wild-type 0.0097 0.027
  heterozygote 0.025  
  homozygote 0.04  
         †The regression coefficients for age were statistically significant in heterozygotes (p<0.001), homozygotes (p=0.004), and all
         genotypes  combined  (p<0.001).  ‡The  regression  coefficients  for  age  were  significantly  different  among  three  genotypes
         (p=0.016)
TABLE 4. SERUM HS-CRP LEVELS BY *372_815DEL443INS54 GENOTYPES.
All ages Number Geometric mean GSD
wild-type 166 (36.6%) 0.372 2.836
heterozygote 226 (49.9%) 0.349 3.379
homozygote 61 (13.5%) 0.409 4.002
total 453 0.365 3.255
Over 60 years old Number Geometric mean GSD
wild-type 36 (35.0%) 0.353 2.261
heterozygote 52 (50.4%) 0.602 3.601
homozygote 15 (4.3%) 0.713 6.19
total 103 0.512 3.52
p values for the difference in geometric means All ages Over 60 years old  
dominant model 0.79 0.011  
recessive model 0.41 0.43  
additive model 0.81 0.032  
         Serum hs-CRP levels on subjects of all ages, over 60 years-old were shown. p values for the difference in geometric means
         among  *372_815del443ins54  genotypes  assuming  dominant,  recessive,  or  additive  gene-dosage  model  were  shown.
         Abbreviations: CRP, C-reactive protein;GSD, geometric standard deviation.
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2927DISCUSSION
In this study, the results suggest the association of the AMD
risk alleles in the ARMS2/HTRA1 gene and an increased rate
of age-dependent elevation in the hs-CRP level in normal
subjects  without  macular  disease.  Consequently,  when
participants over 60 years of age were selected and examined,
the hs-CRP levels were elevated in those carrying one or more
copies  of  the  risk  allele.  Meanwhile,  the  mechanisms
underlying the age-dependent alteration of hs-CRP remains
unknown.
Despite the growing consensus that chronic inflammation
is  an  important  factor  in  the  pathogenesis  of  AMD,  the
association  of  ARMS2/HTRA1  and  systemic  inflammatory
markers, including CRP, has not been reported. In this study,
we produced evidence supporting the notion that the ARMS2/
HTRA1 risk allele for AMD is linked directly or indirectly to
chronic systemic inflammation. Because the elevated CRP is
also associated with increased progression of AMD [16], these
findings suggest that the risk allele might contribute to the
development  and  progression  of  AMD.  Meanwhile,  the
results  of  the  current  study  did  not  include  the  genotype
analyses of the CRP gene in chromosome 1q21-q23, which
might also influence the level of CRP [31]. However, no
association  between  the  CRP  gene  and  AMD  has  been
reported [32,33].
Another AMD risk variant, Y402H in CFH, is reportedly
uncommon among Japanese [34]. Nevertheless, we analyzed
the correlation between the serum hs-CRP levels and CFH
Y402H genotypes (data not shown). The allele frequencies of
Y402H  variants  were  approximately  5%  in  our  study
population, and no measurable difference was found in the
geometric  means  of  hs-CRP  levels  between  genotypes,
possibly because of the small number of subjects with the
Y402H allele. Notably, a previous report found no association
between the Y402H allele and CRP levels in a Caucasian
cohort [35].
To  date,  the  functions  of  ARMS2  and  HTRA1  genes
remain largely unknown. The ARMS2 protein is reportedly
expressed in the retina [26], specifically in the mitochondria-
rich ellipsoid region of the photoreceptors [24]. Together with
results  showing  co-localization  of  the  protein  and
mitochondria in cells transfected with the ARMS2 gene, the
functional role of ARMS2 in mitochondrial homeostasis was
proposed  [24,26].  However,  Arg38X  polymorphism
(rs2736911), presumably resulting in the lack of this gene
product,  is  frequently  found  in  the  non-risk  allele  of  the
ARMS2 gene [19,25], which indicates that the loss of function
of this gene is less likely to contribute to AMD pathogenesis
[25].  Meanwhile,  the  role  of  HTRA1  protein  is  also
incompletely characterized, aside from observations showing
its  expression  in  drusen  from  human  eyes  [27]  and  the
inhibitory role in signaling by transforming growth factor
(TGF)-β family proteins [36,37]. Down-regulation of TGF-β
signaling  might  induce  aberrant  invasion  of  choroidal
vasculatures by promoting proliferation, tube formation, and
migration of vascular endothelial cells [27,38]. Nevertheless,
the current biologic data for these genes are not sufficient
enough to specify which gene or combination of genes is
associated with the inflammation that confers susceptibility
for  AMD.  At  the  same  time,  the  presence  of  another
uncharacterized variation/gene at this locus responsible for
the elevation of CRP and systemic inflammation cannot be
ruled out.
In conclusion, normal subjects with AMD risk alleles in
the ARMS2/HTRA1 locus may be at risk of increased hs-CRP
levels and chronic systemic inflammation with aging, which
probably heightens the risk of developing AMD. The results
of this study provide important insight into the role of gene
variants in the ARMS2/HTRA1 locus, the major genetic risk
for the development of neovascular AMD in Asian people.
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